Targeted niches Focus on high-volume radiology departments performing CT-guided percutaneous procedures like biopsies and ablations, where the XACT ACE robotic system can demonstrate improved accuracy, consistency, and throughput to justify capital investment and installation in busy U.S. and international imaging centers.

Efficiency leverage Position ACE as a tool to reduce procedure time and staff variance, highlighting average setup under eight and a half minutes and a single insertion-to-target outcome to reduce rework, theater time, and patient throughput constraints in oncology and interventional radiology workflows.

Expansion opportunities Leverage small footprint and room-to-room mobility to target hospitals with limited dedicated interventional suites or facilities undergoing rapid expansion, offering scalable adoption without major infrastructure changes.

Clinical validation Emphasize the proven 1.7 mm tip-to-target accuracy and recognition by Frost & Sullivan, using case studies and pre-clinical/clinical data to support procurement discussions with key decision-makers in radiology, oncology, and hospital capital committees.

Strategic partnerships Explore collaborations with imaging centers and medical device distributors to accelerate adoption, including remote extension add-ons like ACE Xtend for teleoperation, and align with sales motions around upgrade paths and service contracts to drive recurring revenue.